The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,030.00
Bid: 2,000.00
Ask: 2,030.00
Change: 40.00 (2.01%)
Spread: 30.00 (1.50%)
Open: 2,000.00
High: 2,030.00
Low: 2,000.00
Prev. Close: 1,990.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow

4 Apr 2022 07:00

Edison Investment Research Limited Edison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow 04-Apr-2022 / 07:00 GMT/BST


 

London, UK, 4 April 2022

 

S&U (SUS): Seeing recovery and adapting to grow

S&U recorded a dramatic increase in profit in FY22, but the more telling point is that average pre-tax profit for FY22 and FY21 was nearly £33m, only slightly below the pre-pandemic level of £35m (FY20). In the meantime, the group has continued to refine and develop both its businesses, which should underpin medium-term growth even if the near-term macro background is uncertain.

Our estimates are increased slightly, with EPS raised by 2% and 3% for FY23 and FY24 respectively. Following the exceptionally low level of loan loss provisions in FY22 we expect a normalisation in FY23, hence the reduction in pre-tax profit between the two years, from £47m to £39m. This still leaves the prospective multiple only just above 9x. The disparity between profits and earnings growth in FY24 is the result of allowing for the increase in corporation tax to 25%. The historical and prospective yield of over 5% should be supportive for the share price.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Andrew Mitchell +44 (0)20 3681 2500 financials@edisongroup.com

Martyn King ++44 (0)20 3077 5745 financials@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1318165 04-Apr-2022 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
10th Apr 20183:13 pmRNSDirector/PDMR Shareholding
27th Mar 20187:00 amRNSPreliminary Results
28th Feb 20183:22 pmRNSNotification of Major Holdings
28th Feb 20183:19 pmRNSNotification of Major Holdings
9th Feb 20187:00 amRNSTrading Statement
7th Dec 20177:00 amRNSTrading Statement
1st Dec 201711:41 amRNSReplacement: Exercise of Options & Voting Rights
29th Nov 20179:35 amRNSBlock Listing Six Monthly Return
18th Oct 20177:00 amRNSExercise of Options and Total Voting Rights
6th Oct 20175:50 pmRNSDirector/PDMR Shareholding and Total Voting Rights
26th Sep 20177:00 amRNSHalf-year Report
4th Aug 20177:00 amRNSTrading Statement
5th Jun 20173:01 pmRNSExercise of Options and Directors' Shareholdings
23rd May 20177:00 amRNSBlock Listing Six Monthly Return
18th May 201712:40 pmRNSResult of AGM
18th May 20177:01 amRNSChange of Adviser
18th May 20177:00 amRNSTrading Statement
20th Apr 20173:28 pmRNSExercise & Sale of Options/Directors Shareholding
13th Apr 20174:24 pmRNSAnnual Financial Report
28th Mar 20177:00 amRNSFinal Results
10th Feb 20177:00 amRNSTrading Statement
19th Dec 20163:42 pmRNSDirector/PDMR Shareholding
14th Dec 201610:40 amRNSDirector/PDMR Shareholding
8th Dec 20167:00 amRNSTrading Statement
6th Dec 201611:26 amRNSDirector/PDMR Shareholding
29th Nov 201612:40 pmRNSDirector/PDMR Shareholdings
29th Nov 201610:47 amRNSDirector/PDMR Shareholding
23rd Nov 20167:00 amRNSBlock Listing Six Monthly Return
22nd Nov 20163:36 pmRNSExercise and Sale of Options
19th Oct 201612:43 pmRNSDirector/PDMR Shareholding
27th Sep 20167:00 amRNSHalf-year Report
5th Aug 20167:00 amRNSTrading Statement
26th Jul 20164:41 pmRNSSecond Price Monitoring Extn
26th Jul 20164:35 pmRNSPrice Monitoring Extension
8th Jul 201611:30 amRNSDirector/PDMR Shareholding
22nd Jun 201612:02 pmRNSPrice Monitoring Extension
16th Jun 20167:00 amRNSAnalyst Day 2016
9th Jun 201611:22 amRNSExercise and Sale of Options
27th May 20163:25 pmRNSDirector/PDMR Shareholding
26th May 20163:20 pmRNSBlock Listing Six Monthly Return
17th May 201612:41 pmRNSResult of AGM
17th May 20167:00 amRNSAGM Statement & Trading Update
3rd May 20169:13 amRNSTotal Voting Rights
15th Apr 20162:49 pmRNSAnnual Report and Accounts
13th Apr 20162:29 pmRNSExercise & Sale of Options/ Directors Shareholding
6th Apr 20164:49 pmRNSDirector/PDMR Shareholding
4th Apr 201612:38 pmRNSBlock Listing Application
22nd Mar 20167:00 amRNSAppointment of Non-Executive Director
22nd Mar 20167:00 amRNSPreliminary Results for Year Ended 31 January 2016
12th Feb 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.